Schulich Medicine & Dentistry bioinformatician Abayomi Olabode uses machine learning to study HIV viruses to develop ...

This study, published in eLife on April 7, 2025, focused on broadly neutralizing antibodies (bNAbs): a class of highly potent immune cells that latch onto a part of the HIV virus known as the ...

Misconceptions about these vaccines stem from misunderstandings about how the immune system and vaccines work. So do they ...

In a significant breakthrough, researchers from Florida Atlantic University’s Charles E. Schmidt College of Medicine have ...

Professor Emeritus Herb Boyer's discovery of recombinant DNA changed medicine, ushering in a new era in biological treatments ...

A novel AI-driven method helps scientists stay ahead of viral evolution by engineering synthetic spike proteins that ...

First Commercial Sales: Humacyte commenced its commercial launch of Symvess in late February 2025 after the first commercial batch was released by the FDA. The first commercial shipments containing ...

Richard Lepke; Senior Director, Investor Relations; Vir Biotechnology Inc. Marianne De Backer; Chief Executive Officer, Director; Vir Biotechnology Inc. Mark Eisner; ...

Choose from Virus Cell stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Plans and pricing Video Back Videos home Signature collection ...

At the level of molecules and cells ... in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus.